Gilad Shabtai serves as Executive at Eloxx Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Gilad Shabtai has executed 4 insider transactions totaling $853.2K, demonstrating a bullish approach to their equity position. Their most recent transaction on Apr 30, 2018 involved purchasing 75,000 shares valued at $731.3K.
Gilad Shabtai currently holds 3,351,770 shares of Eloxx Pharmaceuticals, Inc. (ELOX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Gilad Shabtai has been a net buyer of ELOX stock. They have purchased $853.2K and sold $0 worth of shares.
Gilad Shabtai's most recent insider trade was on Apr 30, 2018, when they purchased 75,000 shares at $9.75 per share.
Get notified when new Form 4 filings are submitted
| $9.58 |
| Discretionary |
| Apr 3, 2018 | ELOX | $53.6K | Purchase | 5,700 | $9.41 | Discretionary |
| Mar 29, 2018 | ELOX | $43.4K | Purchase | 4,500 | $9.64 | Discretionary |